These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3254 related articles for article (PubMed ID: 54436)

  • 1. Cellular microcytotoxicity in human tumor systems: analysis of results.
    Oldham RK; Djeu JY; Cannon GB; Siwarski D; Herberman RB
    J Natl Cancer Inst; 1975 Dec; 55(6):1305-18. PubMed ID: 54436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 4. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
    Vilien M; Wolf H
    J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 6. [The lymphocyte cytotoxicity test in tumor immunology (author's transl)].
    Pees HW
    Klin Wochenschr; 1975 Jan; 53(1):1-6. PubMed ID: 47411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24.
    Catalona WJ; Oldham RK; Herberman RB; Djeu JY; Cannon GB
    J Urol; 1977 Aug; 118(2):254-7. PubMed ID: 330885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
    Saal JG; Rieber EP; Riethmüller G
    Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of microcytotoxicity assay for cell-mediated immunity.
    O'Toole C
    Natl Cancer Inst Monogr; 1973 Jun; 37():19-24. PubMed ID: 4713781
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
    Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
    Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
    Currie GA; Basham C
    Br J Cancer; 1972 Dec; 26(6):427-38. PubMed ID: 4119105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.
    O'Toole C; Stejskal V; Perlmann P; Karlsson M
    J Exp Med; 1974 Mar; 139(3):457-66. PubMed ID: 4591169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 15. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cell-mediated immunity to human tumor-associated antigens.
    Baldwin RW; Embeton MJ
    Int Rev Exp Pathol; 1977; 17():49-95. PubMed ID: 849883
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
    Canevari S; Fossati G; Della Porta G
    J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 163.